Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 23, Issue 3, 2012, Pages 405-411

  Conway, Bryan R ^a,b   Rennie, Jillian ^a   Bailey, Matthew A ^b   Dunbar, Donald R ^b   Manning, Jonathan R ^b   Bellamy, Christopher O ^b   Hughes, Jeremy ^a   Mullins, John J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ALPHA SMOOTH MUSCLE ACTIN; CYTOCHROME P450 1A1; KIDNEY INJURY MOLECULE 1;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETIC NEPHROPATHY; DOWN REGULATION; FIBROSIS; GENE EXPRESSION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TUBULOINTERSTITIAL FIBROSIS; UPREGULATION;

EID: 84857954602     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011060577     Document Type: Article

References (33)

1. US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
2. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T Animal Models of Diabetic Complications Consortium: Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512, 2009
3. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805, 2002 (Pubitemid 34988338)
4. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703-713, 1998
5. Mogensen CE: Combined high blood pressure and glucose in type 2 diabetes: Double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction. BMJ 317: 693-694, 1998
6. Berkman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): Report of a case. Metabolism 22: 715-722, 1973
7. Béroniade VC, Lefebvre R, Falardeau P: Unilateral nodular diabetic glomerulosclerosis: Recurrence of an experiment of nature. Am J Nephrol 7: 55-59, 1987 (Pubitemid 17037528)
8. Cooper ME, Allen TJ, Macmillan P, Bach L, Jerums G, Doyle AE: Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertens 1: 5-10, 1988
9. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 54: 343-352, 1998 (Pubitemid 28357396)
10. Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO: Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 63: 2162-2170, 2003 (Pubitemid 36605827)
11. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541-544, 1990
12. Hartner A, Cordasic N, Klanke B, Wittmann M, Veelken R, Hilgers KF: Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am J Physiol Renal Physiol 292: F820-F827, 2007 (Pubitemid 46220551)
13. Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G, Lammie AG, McGrath I, Kotelevtsev Y, Mullins JJ: Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem276: 36727-36733, 2001
14. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999 (Pubitemid 29518163)
15. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC: Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664-2669, 2006 (Pubitemid 44484656)
16. Kanetsuna Y, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, Takahashi T: Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 170: 1473-1484, 2007 (Pubitemid 47339294)
17. Tesch GH: Macrophages and diabetic nephropathy. Semin Nephrol 30: 290-301, 2010
18. Cohen CD, Lindenmeyer MT, Eichinger F, Hahn A, Seifert M, Moll AG, Schmid H, Kiss E, Gröne E, Gröne HJ, Kretzler M, Werner T, Nelson PJ: Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS ONE 3: e2937, 2008
19. Lim AK, Ma FY, Nikolic-Paterson DJ, Kitching AR, Thomas MC, Tesch GH: Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Diabetologia 53: 1772-1782, 2010
20. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlöndorff D, Cohen CD: Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 18: 1765-1776, 2007 (Pubitemid 46870313)
21. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase. Kidney Int 79: 464-470, 2011
22. Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C, Argetsinger LS, Rastaldi MP, Brosius FC, Kretzler M: Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes 58: 469-477, 2009
23. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239, 1999 (Pubitemid 29521855)
24. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE: VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136, 2008 (Pubitemid 351398487)
25. Liu X, Bellamy CO, Bailey MA, Mullins LJ, Dunbar DR, Kenyon CJ, Brooker G, Kantachuvesiri S, Maratou K, Ashek A, Clark AF, Fleming S, Mullins JJ: Angiotensin-converting enzyme is a modifier of hypertensive end organ damage. J Biol Chem284: 15564-15572, 2009
26. Keppler A, Gretz N, Schmidt R, Kloetzer HM, Groene HJ, Lelongt B, Meyer M, Sadick M, Pill J: Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int 71: 74-78, 2007 (Pubitemid 44967737)
27. Rodríguez-Iturbe B, Quiroz Y, Shahkarami A, Li Z, Vaziri ND: Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int 68: 1041-1047, 2005 (Pubitemid 43246420)
28. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80, 2004
29. Gautier L, Cope L, Bolstad BM, Irizarry RA: Affy - Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315, 2004 (Pubitemid 38262761)
30. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3, 2004
31. Breitling R, Armengaud P, Amtmann A, Herzyk P: Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92, 2004 (Pubitemid 39141040)
32. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G The Gene Ontology Consortium: Gene ontology: Tool for the unification of biology. Nat Genet 25: 25-29, 2000 (Pubitemid 30257031)
33. Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009